Efficacy and feasibility of dose-dense neoadjuvant chemotherapy versus conventional neoadjuvant chemotherapy in patients with HER2-negative breast cancer: A single-center retrospective study

Authors
Publication date
30 March 2023
Publisher
Nagasaki University School of Medicine

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Institutional Repositories DataBase (IRDB)

    redirect
    oaioai:irdb.nii.ac.jp:01160:00057...
    Last time updated on 02/04/2023